ENAD-DET-01 helps Seoul endoscopists find more adenomas

In a two-hospital Seoul trial of 998 patients, colonoscopy with Ainex's ENAD-DET-01 found adenomas in 52.3% of patients against 36.1% with standard colonoscopy.

32
Benefit status
Reported
Evidence
Independently studied
Observed
Sources
1 publication
Download data CiteSuggest a correction

Benefits

Benefit

Found adenomas in 52.3% of patients against 36.1% with standard colonoscopy

Awaiting review

Outcome identifiers

Unresolved

Not reviewedUnresolved

Category

Improved Task Accuracy

Awaiting review

Status

Reported benefit

Awaiting review

Beneficiary groups

People. Organizations.

Awaiting review

Beneficiaries

Unresolved

Not reviewedUnresolved

Reach

Unresolved

Not reviewedUnresolved

Distribution and access

Unresolved

Not reviewedUnresolved

Duration

Unresolved

Not reviewedUnresolved

Expected?

Yes

Awaiting review

Costs and harms

Unresolved

Not reviewedUnresolved

AI system

System

ENAD-DET-01 (ENdoscopy as AI-powered Device)

Awaiting review

Model

This is an explicit unresolved assignment: the sources on record do not settle this question.

Not reviewedUnresolved

Release

Unresolved

Not reviewedUnresolved

Provider

Unresolved

Not reviewedUnresolved

Role

Unresolved

Not reviewedUnresolved

Configuration

Unresolved

Not reviewedUnresolved

Inputs and outputs

Unresolved

Not reviewedUnresolved

Autonomy

Unresolved

Not reviewedUnresolved

Workflow

The system marked suspected polyps on the live endoscopy monitor. Endoscopists at two tertiary hospitals used it in screening, surveillance and diagnostic colonoscopy. The control group's adenoma detection rate was 36.1%.

Awaiting review

Human oversight

Unresolved

Not reviewedUnresolved

Relation to AI

Patients were randomly assigned to colonoscopy with or without the system, so the difference in detection is attributable to the system.

Awaiting review

AI contribution

Patients were randomly assigned to colonoscopy with or without the system, so the difference in detection is attributable to the system.

Awaiting review

Measurement

Studies

Randomized. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Study design

Randomized. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Measurement

Histologically confirmed adenomas per patient. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Setting and sample

998 patients at two tertiary hospitals in Seoul, May 2023 to April 2025. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Measures

Adenoma detection rate. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Comparison

Conventional colonoscopy. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Results

52.3% vs 36.1%; polyp detection 72.2% vs 54.5%. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Additional value from AI

16.2 percentage points in adenoma detection. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Limitations

Two hospitals; no gain for sessile serrated lesions or cancers. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Denominators

System used throughout colonoscopy in the intervention group. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Materials for replication

Registered as KCT0009664. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Money

Kind of value

The kind of monetary value is unclear.

Not reviewedUnresolved

Amount

The monetary value is not established.

Not reviewedUnresolved

Currency and prices

The currency and price basis are unclear.

Not reviewedUnresolved

Period and unit

The period and unit of the monetary estimate are unclear.

Not reviewedUnresolved

Realization

Whether the monetary value was realized is unclear.

Not reviewedUnresolved

Recipients and payers

The recipients and payers are unclear.

Not reviewedUnresolved

Gross or net

Whether the monetary figure includes costs is unclear.

Not reviewedUnresolved

Included costs

The costs included in the estimate are unclear.

Not reviewedUnresolved

Comparison

The financial comparison is not established.

Not reviewedUnresolved

Method

The method used to calculate monetary value is unclear.

Not reviewedUnresolved

Return and payback

The return on investment or payback period is not established.

Not reviewedUnresolved

People and places

Participants

Developer: Ainex Corporation. Operator: Korea University Medical Center and Ewha Womans University Medical Center.

Awaiting review

Jurisdictions

Benefit: Seoul, South Korea. Developer: South Korea. Operator: South Korea.

Awaiting review

Ownership and control

Unresolved

Not reviewedUnresolved

Dependencies

Unresolved

Not reviewedUnresolved

Cross-border connections

Unresolved

Not reviewedUnresolved

Geopolitical implications

The geopolitical implications are unclear.

Not reviewedUnresolved

Follow-up

Conditions for replication

The system must run on a compatible endoscopy processor. Baseline detection must leave room for improvement.

Awaiting review

Replication attempts

2 follow-up entries. Benefit recurred: 1. Benefit did not recur: 1.

Awaiting review

Later findings

Unresolved

Not reviewedUnresolved

Availability

Unresolved

Not reviewedUnresolved

Institutional decision

A relevant institutional decision has not been established.

Not reviewedUnresolved

Grounds

The grounds for an institutional decision are unclear.

Not reviewedUnresolved

Action and result

The result of an institutional decision is not established.

Not reviewedUnresolved

Success criterion

The criterion for a successful institutional decision is unclear.

Not reviewedUnresolved

Evidence

Source numbers

AIBD-0646-source-0001–0002

Awaiting review

Citations

Numbered references below.

Awaiting review

Language

Unresolved

Not reviewedUnresolved

Source relationships

Independent

Awaiting review

Original evidence

Unresolved

Not reviewedUnresolved

Access and versions

Unresolved

Not reviewedUnresolved

Supported findings

Unresolved

Not reviewedUnresolved

Evidence strength

Independently studied. Sources: one independent peer-reviewed study. The cited evidence includes no finding by a regulator or court. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Missing evidence

Unresolved

Not reviewedUnresolved

Grades

Assessed benefits

People. Organizations.

Awaiting review

Depth

People: 3. Organizations: 2.

Awaiting review

Reasons

People: Adenomas, which are precursors of colorectal cancer, were found and removed in 52.3% of patients with the system against 36.1% without. Organizations: The hospitals raised adenomas found per colonoscopy from 0.8 to 1.2.

Awaiting review

Observed or intended

Unresolved

Not reviewedUnresolved

Rubric

Unresolved

Not reviewedUnresolved

Assessor and date

Unresolved

Not reviewedUnresolved

Alternative assessments

Unresolved

Not reviewedUnresolved

Fill

Independently studied

Awaiting review

Entry details

Kind

The case describes an evaluation or a study. A prospective multicenter randomized controlled trial. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Field

Healthcare.

Awaiting review

Purpose

ENAD-DET-01 was built to detect colorectal polyps on the live colonoscopy video. The higher adenoma detection was that purpose.

Awaiting review

Dates

Observed: April 2025. Updated: 29 October 2026.

Awaiting review

Stage

The system was used in a pilot. A randomized trial at two hospitals. [1]

Fully reviewed

Review date: 29 October 2026.

Sources: [1]

Version

SHA-256: 505ea79c604f…

Awaiting review

SHA-256 of the public case, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary.

References

Other identifiers

Unresolved

Not reviewedUnresolved

Category mappings

Unresolved

Not reviewedUnresolved

Citable summary

Unresolved

Not reviewedUnresolved

Revisions

1 revision. Latest: 29 October 2026.

Awaiting review

Sources

  1. Peer-reviewed study Independent author

    Jeon HJ, Keum B, Jeong ES, et al. Clinical Efficacy of Real-Time Artificial Intelligence-Assisted Colonoscopy in Colorectal Polyp Detection: A Prospective Multicenter Randomized Controlled Trial. Gut Liver. 2026;20(1):97-106. doi:10.5009/gnl250369

Cite this case

BibTeX Download BibTeX

Version 505ea79c604f, archived in the edition of 29 October 2026

Benefit marks

Depth

The number and color show the depth of a benefit.

  1. A convenience, or time or money saved.
  2. A measurable improvement in a result or ability.
  3. A lasting change, an ability restored, or a risk removed.
  4. A serious harm averted or a serious condition resolved in time.
  5. A life or livelihood preserved, or a change documented across a population.

Beneficiary

  • Circle: a person
  • Square: an organization
  • Triangle: society

Evidence

  • Solid. A court or regulator found a benefit, or researchers independently studied it.

  • Hatched. Independent reporting.

  • Outline. Claimed by the parties. Only the people or organizations involved, or sources whose independence has not been assessed, support the benefit.

The fill changes with the evidence. The depth color stays the same.

How benefits are assessed